Telavancin CAS# 372151-71-8 特拉万星
Telavancin a semisynthetic lipoglycopeptide vancomycin-derivative and antimicrobial agent developed by Theravance for overcoming resistant Gram-positive bacterial infections, specifically methicillin-resistant Staphylococcus aureus (MRSA).
📌 参考资料/链接:
Leadbetter, Michael R.; Adams, Stacy M.; Bazzini, Bettina; Fatheree, Paul R.; Karr, Dane E.; Krause, Kevin M.; Lam, Bernice M. T.; Linsell, Martin S.; Nodwell, Matthew B.; Pace, John L.; Quast, Kelly; Shaw, Jeng-Pyng; Soriano, Elizabeth; Trapp, Sean G.; Villena, Jenny D.; Wu, Terry X.; Christensen, Burton G.; Judice, J. Kevin. Hydrophobic vancomycin derivatives with improved ADME properties: Discovery of telavancin (TD-6424). Journal of Antibiotics. Volume 57. Issue 5. Pages 326-336. 2004.
📄 详细内容
CAS No. 372151-71-8 特拉万星Telavancin synthetic routes

Leadbetter, Michael R.; Adams, Stacy M.; Bazzini, Bettina; Fatheree, Paul R.; Karr, Dane E.; Krause, Kevin M.; Lam, Bernice M. T.; Linsell, Martin S.; Nodwell, Matthew B.; Pace, John L.; Quast, Kelly; Shaw, Jeng-Pyng; Soriano, Elizabeth; Trapp, Sean G.; Villena, Jenny D.; Wu, Terry X.; Christensen, Burton G.; Judice, J. Kevin. Hydrophobic vancomycin derivatives with improved ADME properties: Discovery of telavancin (TD-6424). Journal of Antibiotics. Volume 57. Issue 5. Pages 326-336. 2004.
产品链接: CAS No. 372151-71-8 ››